Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-46,380
Closed -$284K 876
2025
Q3
$284K Sell
46,380
-107,270
-70% -$679K 0.01% 624
2025
Q2
$996K Buy
+153,650
New +$828K 0.02% 325
2022
Q2
Sell
-9,600
Closed -$277K 789
2022
Q1
$277K Buy
+9,600
New +$264K 0.01% 559
2021
Q4
Sell
-9,400
Closed -$255K 784
2021
Q3
$255K Buy
+9,400
New +$251K 0.01% 592
2019
Q3
Sell
-10,700
Closed -$236K 591
2019
Q2
$236K Buy
+10,700
New +$248K 0.01% 464

Other funds holding TBI

Bailard's TBI Position: Q4 2025 in Review

Bailard sold out of Trueblue (TBI) in Q4 2025, closing a stake of 46,380 shares — an estimated $284K sold.

Bailard first reported a position in TBI in Q2 2019 and held it in 5 quarters. The position peaked at $996K in Q2 2025. 110 funds tracked by Wall St. Rank hold TBI as of Q4 2025.

  • Bailard reported no remaining Trueblue position as of Q4 2025 after selling out during the quarter.
  • Bailard sold 46,380 Trueblue shares in Q4 2025, an estimated $284K.
  • Bailard first reported a position in Trueblue in Q2 2019 and held it in 5 quarters.
  • Bailard's Trueblue position peaked at $996K in Q2 2025.
  • 110 funds tracked by Wall St. Rank held Trueblue as of Q4 2025.

Based on Bailard's 13F filing for Q4 2025, filed 4 Feb 2026.